CNS stimulants, including VYVANSE, employed to treat ADHD are associated with peripheral vasculopathy, together with Raynaud's phenomenon. Signals and signs are usually intermittent and delicate; nevertheless, sequelae have included electronic ulceration and/or comfortable tissue breakdown. Results of peripheral vasculopathy, which includes Raynaud